Prognostic value of chemotherapy-induced leukopenia in small-cell lung cancer

OBJECTIVE: Chemotherapy is the standard treatment for small-cell lung cancer (SCLC), and leukopenia is a common side effect. This study assesses whether chemotherapy-induced leukopenia is a predictor of efficacy and whether it is associated with the survival of SCLC patients. METHODS: A retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wei, Zhang, Cui-Cui, Li, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719195/
https://www.ncbi.nlm.nih.gov/pubmed/23882424
http://dx.doi.org/10.7497/j.issn.2095-3941.2013.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719195/
https://www.ncbi.nlm.nih.gov/pubmed/23882424
http://dx.doi.org/10.7497/j.issn.2095-3941.2013.02.005

Ejemplares similares